Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01695954
Recruitment Status : Unknown
Verified September 2012 by New York University School of Medicine.
Recruitment status was:  Active, not recruiting
First Posted : September 28, 2012
Last Update Posted : September 28, 2012
Bellevue/NYU AIDS Clinical Trials Unit
Kowa Pharmaceuticals America, Inc.
University at Buffalo
Information provided by (Responsible Party):
New York University School of Medicine

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2012
  Estimated Study Completion Date : October 2012

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 22, 2014
March 5, 2014
2 March 10, 2014
April 14, 2014
3 May 4, 2016
June 3, 2016
4 June 9, 2016
July 20, 2016
5 July 25, 2016
September 8, 2016
6 October 13, 2016
December 6, 2016
7 December 8, 2016
February 1, 2017
8 August 8, 2017
February 16, 2018
9 April 23, 2018